Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

Bertges Clinical Trial Mentioned in Cardiovascular Business News

November 4, 2022 by Lucy Gardner Carson

(NOVEMBER 4, 2022) Professor of Surgery and UVMMC vascular surgeon Daniel J. Bertges, M.D., presented a clinical trial on paclitaxel drug-coated balloons (DCBs) at the VIVA Foundation’s VIVA22 conference in Las Vegas, according to CardiovascularBusiness.com.

Daniel J. Bertges, M.D.

(NOVEMBER 4, 2022) UVMMC vascular surgeon Daniel J. Bertges, M.D., professor of surgery, presented a late-breaking clinical trial on paclitaxel drug-coated balloons (DCBs) at the VIVA Foundation’s VIVA22 conference in Las Vegas, the news site CardiovascularBusiness.com reported in an article titled Drug-Coated Balloons an Effective Tool in the Battle Against Femoropopliteal Disease.” Results of the trial, which focused on Medtronic’s IN.PACT Admiral DCBs, indicated that DCBs are an effective option for the treatment of femoropopliteal artery disease and femoropopliteal in-stent restenosis.

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.

Check out our newsletter archive:

December 2021

March 2022

August 2022

SpecialEditionAug2022

June 2023

Fall 2023

Winter 2024

Spring 2024

Summer 2024

Fall 2024

Questions?

Please email us with any questions or for assistance accessing services.

Become a Member

All NNE-CTR members have access to our services and support. Learn more about the free benefits of membership, and join today!